Skip to content

Antibiotics Versus Surgery in Acute Appendicitis

Antibiotics vs.Surgery in Acute Appendicitis;an Intention to Treat Prospective Randomised Study. The ASAA-study

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01421901
Acronym
ASAA
Enrollment
218
Registered
2011-08-23
Start date
2011-08-31
Completion date
2015-06-30
Last updated
2014-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Appendicitis Without Peritonitis

Keywords

Acute appendicitis, Surgery, Antibiotics, comparison surgery and antibiotics, resolutions of symptoms

Brief summary

The acute appendicitis (AA) is a very common disease with a life time risk 7-8% and the highest incidence in the second decades . The aetiology of AA is still poor understood: the commonest hypothesis refers to appendix obstruction followed by impairment of wall appendix barrier and thus wall perforation and/or abscess formation1. However some studies suggest that no-complicate and complicate appendicitis are different entities allowing a different treatment. The study aims to test the no inferiority in terms of efficacy of antibiotic treatment compared to surgery in a population with high probability to suffer of 1st episode of AA.The study aims to test the no inferiority in terms of efficacy of antibiotic treatment compared to surgery in a population with high probability to suffer of 1st episode of AA.

Interventions

DRUGErtapenem

Ertapenem i.v,m 1g, once a day, 3 days

PROCEDUREappendectomy

Sponsors

A.O. Ospedale Papa Giovanni XXIII
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* patients between 18 and 65 years old * first episode of suspected AA diagnosed by Andersson's score or combination with abdominal ultrasound

Exclusion criteria

* patients with any potential immunodeficiency status * assumption of antibiotics for different infectious disease or surgery in the last 30 days * allergy to antibiotics established in the study protocol * no acceptance of study protocol * pregnancy or delivery in the last 6 months * ASA IV or V, no Italian or English fluently speakers.

Design outcomes

Primary

MeasureTime frame
the rate of patients free of symptoms into 2 weeks (from operation in the surgery group or from the third Ertapenem administration in the antibiotics group) with no pain, no fever, WBC ≤ 10000, CRP ≤ 12 weeks

Secondary

MeasureTime frameDescription
Secondary outcomes will be considered major complications occurring after 2 weeks and into 1 year. Phone consultation will be performed at 1 year2 weeks- One year1. Surgery: Rate of reintervention due to bowel occlusion (idro fluid level at Abdomen xRay and/no resolution by Gasytograffin) or intraperitoneal abscess; incisional hernia or wound dehiscence. 2. Antibiotic: Rate of Diagnosis of new AA. We will register also the rate of intervention for bowel occlusion longer than 48 hours (no passage of flatus, vomit or combination) or intraperitoneal abscess. Further secondary outcome are Wound infection, negative appendectomy. Hospital stay and work absence.

Countries

Italy

Contacts

Primary ContactMichele Pisano, Principal investigator
mpisano@hpg23.it0039 0352673412

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026